Revenio Group Corporation (REG1V) - Total Assets
Based on the latest financial reports, Revenio Group Corporation (REG1V) holds total assets worth €148.20 Million EUR (≈ $173.26 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See REG1V share price today for real-time trading data and today's change.
Revenio Group Corporation - Total Assets Trend (2000–2025)
This chart illustrates how Revenio Group Corporation's total assets have evolved over time, based on quarterly financial data. Also see Revenio Group Corporation cash conversion from operations for how efficiently the company converts equity into cash flow.
Revenio Group Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
Revenio Group Corporation's total assets of €148.20 Million consist of 35.1% current assets and 64.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 17.4% |
| Accounts Receivable | €15.80 Million | 10.5% |
| Inventory | €10.80 Million | 7.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €23.30 Million | 15.5% |
| Goodwill | €62.90 Million | 41.8% |
Asset Composition Trend (2000–2025)
This chart illustrates how Revenio Group Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Revenio Group Corporation working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Revenio Group Corporation's current assets represent 35.1% of total assets in 2025, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 17.4% of total assets in 2025, up from 10.5% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, an increase from 4.0% in 2000.
- Asset Diversification: The largest asset category is goodwill at 41.8% of total assets.
Revenio Group Corporation Competitors by Total Assets
Key competitors of Revenio Group Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Establishment Labs Holdings Inc
NASDAQ:ESTA
|
USA | $351.93 Million |
|
SonoScape Medical Corp
SHE:300633
|
China | CN¥4.30 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
|
China | CN¥1.42 Billion |
|
Paxman AB
ST:PAX
|
Sweden | Skr487.65 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
Revenio Group Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.26 | 2.75 | 1.86 |
| Quick Ratio | 1.76 | 2.18 | 1.48 |
| Cash Ratio | 0.00 | 1.31 | 0.00 |
| Working Capital | €28.20 Million | €29.60 Million | €12.80 Million |
Revenio Group Corporation - Advanced Valuation Insights
This section examines the relationship between Revenio Group Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.09 |
| Latest Market Cap to Assets Ratio | 2.38 |
| Asset Growth Rate (YoY) | 6.6% |
| Total Assets | €150.60 Million |
| Market Capitalization | $358.98 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Revenio Group Corporation's assets at a significant premium (2.38x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Revenio Group Corporation's assets grew by 6.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Revenio Group Corporation (2000–2025)
The table below shows the annual total assets of Revenio Group Corporation from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €150.60 Million ≈ $176.07 Million |
+6.55% |
| 2024-12-31 | €141.34 Million ≈ $165.24 Million |
+2.86% |
| 2023-12-31 | €137.41 Million ≈ $160.65 Million |
+0.97% |
| 2022-12-31 | €136.09 Million ≈ $159.10 Million |
+9.24% |
| 2021-12-31 | €124.58 Million ≈ $145.65 Million |
+8.88% |
| 2020-12-31 | €114.42 Million ≈ $133.77 Million |
+4.22% |
| 2019-12-31 | €109.79 Million ≈ $128.36 Million |
+396.95% |
| 2018-12-31 | €22.09 Million ≈ $25.83 Million |
+16.02% |
| 2017-12-31 | €19.04 Million ≈ $22.26 Million |
+0.36% |
| 2016-12-31 | €18.98 Million ≈ $22.18 Million |
+2.99% |
| 2015-12-31 | €18.43 Million ≈ $21.54 Million |
-4.71% |
| 2014-12-31 | €19.34 Million ≈ $22.61 Million |
-14.58% |
| 2013-12-31 | €22.64 Million ≈ $26.46 Million |
-9.47% |
| 2012-12-31 | €25.00 Million ≈ $29.23 Million |
+0.99% |
| 2011-12-31 | €24.76 Million ≈ $28.94 Million |
+1.11% |
| 2010-12-31 | €24.48 Million ≈ $28.63 Million |
-7.84% |
| 2009-12-31 | €26.57 Million ≈ $31.06 Million |
-8.19% |
| 2008-12-31 | €28.94 Million ≈ $33.83 Million |
-28.75% |
| 2007-12-31 | €40.62 Million ≈ $47.48 Million |
+135.84% |
| 2006-12-31 | €17.22 Million ≈ $20.13 Million |
+60.04% |
| 2005-12-31 | €10.76 Million ≈ $12.58 Million |
+90.88% |
| 2004-12-31 | €5.64 Million ≈ $6.59 Million |
-13.54% |
| 2003-12-31 | €6.52 Million ≈ $7.62 Million |
-45.33% |
| 2002-12-31 | €11.93 Million ≈ $13.94 Million |
-51.89% |
| 2001-12-31 | €24.79 Million ≈ $28.98 Million |
-37.45% |
| 2001-09-30 | €39.63 Million ≈ $46.34 Million |
-11.46% |
| 2000-12-31 | €44.76 Million ≈ $52.33 Million |
-- |
About Revenio Group Corporation
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pr… Read more